Checkpoint Therapeutics, Inc. financial data

Symbol
CKPT on Nasdaq
Location
Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 68 % +128%
Debt-to-equity -313 % -119%
Return On Equity 916 % +187%
Return On Assets -431 % +42.6%
Operating Margin -50.6K %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 83.1M shares +137%
Entity Public Float 69.3M USD +110%
Common Stock, Value, Issued 8K USD
Weighted Average Number of Shares Outstanding, Basic 59.8M shares +81.7%
Weighted Average Number of Shares Outstanding, Diluted 59.8M shares +81.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 41K USD +32.3%
Research and Development Expense 31.4M USD -13.2%
General and Administrative Expense 25M USD +182%
Operating Income (Loss) -56.4M USD -25.2%
Nonoperating Income (Expense) -132K USD +98.2%
Net Income (Loss) Attributable to Parent -56.5M USD -8.01%
Earnings Per Share, Basic -1 USD/shares +51%
Earnings Per Share, Diluted -1 USD/shares +51%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33M USD +194%
Other Assets, Current 31K USD -35.4%
Assets, Current 34.2M USD +185%
Assets 34.2M USD +185%
Accounts Payable, Current 5.11M USD -57.1%
Employee-related Liabilities, Current 554K USD +27.4%
Liabilities, Current 17.9M USD -19.6%
Liabilities 17.9M USD -19.6%
Retained Earnings (Accumulated Deficit) -382M USD -17.4%
Stockholders' Equity Attributable to Parent 16.3M USD
Liabilities and Equity 34.2M USD +185%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD -80.5%
Net Cash Provided by (Used in) Financing Activities 38.1M USD +198%
Common Stock, Shares Authorized 175M shares +119%
Common Stock, Shares, Issued 83.1M shares +137%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.4M USD +319%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33M USD +194%
Deferred Tax Assets, Valuation Allowance 89.4M USD +2.46%
Deferred Tax Assets, Gross 89.4M USD +2.46%
Deferred Tax Assets, Operating Loss Carryforwards 51.3M USD +14%
Additional Paid in Capital 398M USD +27.7%